Intravenous nitroglycerin tolerance in patients with ischemic cardiomyopathy and congestive heart failure

Pharmacotherapy

Volumn 18, Issue 1, 1998, Pages 203-209

  Earl, Grace L ^a,c   Stanek, Eric J ^b,c   Spinler, Sarah A ^b,c  

^a Department of Anesthesiology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; ANGINA PECTORIS; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; DRUG BLOOD LEVEL; DRUG TOLERANCE; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEMODYNAMIC MONITORING; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEAN ARTERIAL PRESSURE;

BLOOD PRESSURE; DRUG TOLERANCE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 0031965317     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Braunwald E, Sobel BE. Coronary blood flow and myocardial ischemia. In: Braundwald E, ed. Heart disease: a textbook of cardiovascular medicine. Philadelphia: WB Saunders, 1992:1172.
2. Dupuis J, Lalonde G, Lebeau R, Bichet D, Rouleau JL. Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. Am Heart J 1990;120:625-37.
3. Elkayam U, Kulick D, McIntosh N, Roth A, Hsueh W, Rahimtoola SH. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 1987;76:577-84.
4. Zimrin D, Reichek N, Bogin KT, et al. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 1988;77:1376-84.
5. Abrams J. Interactions between organic nitrates and thiol groups. Am J Med 1991;91(suppl 3C):106S-12.
6. Elkayam U, Mehra A, Shotan A, Ostrzega E. Nitrate resistance and tolerance: potential limitations in the treatment of congestive heart failure. Am J Cardiol 1992;70:98B-104.
7. Elkayam U, Kulick D, Roth A, McIntosh N, Weber L, Rahimtoola SH. Early tolerance to oral nitrate therapy in patients with chronic heart failure: effect of dosing intervals. Circulation 1987;76(suppl):256.
8. Elkayam U, Jamison M, Roth A, Kulick D, Vasquez J, Rahimtoola SH. Oral isosorbide dinitrate in chronic heart failure: tolerance development to QID versus TID regimen. J Am Coll Cardiol 1989;13:178A.
9. Sharpe DN, Coxon R. Nitroglycerin in a transdermal therapeutic system in chronic heart failure. J Cardiovasc Pharmacol 1984;6:76-82.
10. Elkayam U, Roth A, Henriquez B, Weber L, Tonnemarker D, Rahimtoola SH. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure. Am J Cardiol 1985;56:555-9.
11. Packer M, Medina N, Yushak M, Lee WH. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure. Am J Cardiol 1986;56:260-7.
12. Roth A, Kulick D, Freidenberger L, Hong R, Rhimtoola SH, Elkayam V. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure. J Am Coll Cardiol 1987;9: 858-64.
13. Jordon RA, Seth L, Casebolt P, Hayes MJ, Wilen MM, Franciosa J. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. Ann Intern Med 1986;104:295-8.
14. Parker JO, Farrell B, Lahey KA, Rose BF. Nitrate tolerance: the lack of effect of N-acetylcysteine. Circulation 1987;76:572-6.
15. Steering Committee, Transdermal Nitroglycerin Cooperative Study. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Am J Cardiol 1991;68:1263-73.
16. Luke R, Sharpe N, Coxon R. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application. J Am Coll Cardiol 1987;10:642-6.
17. DeMots H. Glasser SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol 1989;13:786-93.
18. Gumbrielle T, Freedman SB, Fogarty L, Ogasawara S, Sobb P, Kelly DT. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina. Eur Heart J 1992;13:671-8
19. Schaer DH, Buff LA, Katz RJ. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am J Cardiol 1988;61:46-50.
20. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987;317:799-804.
21. Thadani U, Sharma M, Thompson D, Prasad R, Goli V, Corn C. Intravenous nitroglycerin and tolerance in unstable angina. Circulation 1987;76(suppl):IV128.
22. Dakak N, Makhoul N, Flugelman M, et al. Failure of captopril to prevent nitrate tolerance in ongestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;66:608-13.
23. Dupuis J, Lalonde G, Bichet D, Rouleau J. Captopril does not prevent nitroglycerin tolerance in heart failure. Can J Cardiol 1990;6:281-6.
24. Parker JD, Parker JO. Effect of therapy with angiotensinconverting enzyme inhibitor on hemodynamic and counter-regulatory responses during continuous therapy with nitroglycerin. J Am Coll Cardiol 1993;21:1445-53.
25. Mohanty N, Wasserman AG, Walker P, Katz RJ. Prevention of nitroglycerin tolerance with diuretics. Am Heart J 1995; 130:522-7.